GLOBAL: Vaccine Experts Meeting in India to Promote Injection Safety

Important note: Information in this article was accurate in 2005. The state of the art may have changed since the publication date.

GLOBAL: Vaccine Experts Meeting in India to Promote Injection Safety

Associated Press (12.06.05) - Wednesday, December 07, 2005

At a meeting in New Delhi, India, the Global Alliance for Vaccines and Immunization said its distribution of single-use syringes has protected millions of children from infection with diseases like HIV/AIDS and hepatitis. The syringes automatically disable themselves after one use, and GAVI said it has distributed 1.214 billion of them in developing nations where syringes are often reused, leading to the spread of disease.

An estimated 17 percent of injections worldwide are administered with unsterilized, reused syringes, according to the World Health Organization, which blames the practice for a "silent epidemic" of 22 million hepatitis infections and 250,000 HIV infections each year. India has both one of the world's biggest injection programs and possibly the poorest record of injection safety. About 70 percent of the nation's 4 billion injections annually are administered improperly or with contaminated syringes, the World Bank has reported.

Since its 2000 launch by the UN, the Bill and Melinda Gates Foundation, governments and the vaccine industry, GAVI says its work has prevented more than 670,000 premature deaths. Vaccine-preventable infections kill about 2 million people every year, chiefly in developing nations. The conference concludes Friday.
051207
AD052466

Copyright © 2005 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2005. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2005. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.